BL Pharmtech equity acquisition/disposal: Gwangdong Health Bio

BL Pharmtech · KOSDAQ · 065170 · Nov 5, 2026 · Equity acquisitions and disposals

BL Pharmtech filed an equity acquisitions and disposals report on Nov 5, 2026. The target company named in the filing is Gwangdong Health Bio Co., Ltd.

Key facts

Target companyGwangdong Health Bio Co., Ltd.

Comparison

Revenue 2025₩6.5bn
Revenue 2024₩8.8bn
Revenue 2023₩24.5bn

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)